HUE030407T2 - Tumor vakcinázás - Google Patents
Tumor vakcinázás Download PDFInfo
- Publication number
- HUE030407T2 HUE030407T2 HUE13756090A HUE13756090A HUE030407T2 HU E030407 T2 HUE030407 T2 HU E030407T2 HU E13756090 A HUE13756090 A HU E13756090A HU E13756090 A HUE13756090 A HU E13756090A HU E030407 T2 HUE030407 T2 HU E030407T2
- Authority
- HU
- Hungary
- Prior art keywords
- cancer
- tumor
- cells
- treatment
- capacitive coupling
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Radiology & Medical Imaging (AREA)
- Botany (AREA)
- Immunology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Claims (4)
- Szabadalmi igénypontok L ^0«}*s|3eeillxäs inunnristinmlásts printer rák és mctasxiázh&i nern-iovaziv kezdésében történő alkalmazásra vagy a tökbetegség viss^esésénéi. m^plSyMbétt tMÉtö. *lfcstomtá$s?8 vagy rák kialakulására megnövekedeit: kockázatú emberek nem-mvaztv vakdnázásában történd alkalmazásra, amely nem-specifikusmmmutsimtöläns tádioS^^^ii^ Jiem4w^^t»ÎSii^Va'kàp!â0lt|Y:' kapcsolás álkaltöatösávai kotädenzätotteltötsdezesbem %Á%: I- Igénypont szétloi.
- Mm-tgtecSiskus alkamtszásra, stó a kondenzátor eberutezés legalább egy dekttdiái és lepilfeb egy elienemlekltööst tartalmaz, aboi a páciens a diiekeirotnos •anyag közötittfe
- 3, Az 1, avagy 2, igénypont szerinti nem-specifikus íumrunstinntiáutí aUodnmzásra, alto! nincs a mdláeiös kapcsoiásü :Rf sirendczési-e/ hasontö antenna alkalmazva a ;4dliaä^kwnaiM%ulM^tök':Mnital^.ra.
- 4, Az előző igénypontok bánnelyiks: szerinti nem-specifikus Immunstirnaláns alkalmazásra, ahöl a nem-invazivan atkáiinazoti rádtofekverseiás kullamok szisztémásán vaunak bejuttatva. Sí Az előző : igénypontok bármelyik« szerinti nmt-speeifikus imnmnsíbnuláns alkalmazásra, ahol ». bejuttatott nem^hvazíkaB Äalmazott töthofekvenciás kallámok nem növelik a páciens lesíbőmérsékieté? vagy a páciens kezelt területének a hőmérsékletét. ff. Az elozdi igénypontok: bármelyike szerinti: nem-spéeáfikus imunmsfiínuláns alkalmazásra, ahol »;. nem-spsciílkas immpnsdtöaiáns sktivâlia a páciens tmnmmvmdszeréi és a &φ0»ίοιί kapádtív kapcsolást kondenzátor elrendezéssel: alkslmazilnem-mvtszfvan alkalmazott tödiotörkveneiás bullámöldtöl együtt vakeioa-ItatáSt hlztösit a tökbetegség elten a ráksejtek Msm8eésire?ês.»%U835tifâ8âfa képes memóriasejtek kiaktkiíssávalv A Az élözö igénypontok bármelyike szerinti nem-specifikus immun stimuláns aikalmazásr% ahol á nermspeeifikus imtöunsilomláns a következők által; alkotott csoportból van kiválasztva; fipopoliszaeehatidük, laelliöS Galmtötö-QÄin. ekirakmtsa, Plçlhanil, Apcsr, Jíiao-Aiptng, Leukineiz (sarpamestlm; relombrnäns graoulodta-macroíág kolónia· stimuláló íakior}, clölt Corynebacierhm pannm baktériumok és cxíraklumai. Ipilimmnab {ciíötoxskus T-iimlbehaooszocialt antigén 4 elleni ellenanyag)., I.evanusot, Kl.II fteiütösesiga Hemoeianink áiaosony döztsö; eiszplatin vagy karboplatin 0,4 rng/kgj. JazestsdMo (íT4gj tg dezoyikolsav (DCA). :8, Az előző igényptöttok Mrtnelyike szerinti alkalmazásra, aboi az áttétek és tt printer rák a következők által alkotott csoportból vannak kiválasztva: adeoekmcmörna, ézhártya .meianöms, akut leukémia akusztikus neufinőnt^ ampuitáris karelooma, attáilx fcarctöőma, astöroeítötna, bazélls sejt karcméma, basnyálmirigy-rák, dezmoid: tumor, Mgyhölyagmk, btönrÉtális kammőma, nem kissejtes tüdőtök (MSCktök etÄ®*, B«riíittéiSmfóm»»...:kmpus» rák, Cltíbszindróma fismernttéo omdero karetöőms}, koiorektáiis rák, vékonybél rák, vékonybél daganatok, petefészkeik, > tiisÄlw ependymoma, epiteliális rák %nsok, Ewing-tomor, gyomor-bélrendszeri tumorok, gyomotrák, epeltéípg i#g epehölyag hűgyhőiyag kareínoma, mehr#:, méhnyaktök, méhnyak glioblasztomák, nőgyógyászati daganatok: főkört-gégészeti tumorok, bematoiogiai rteoplàziàk, szőrsejtes leukémia, itügycsőrák, bőrrák, bervbörrák, agydagattatok (gítornák), agyi áttétek, hererák, hipofízis tumor, karol nokiok, Kaposi-szarkbina, gégerák, vsirasvit daganatok, csontrák, kolorektátis karcktőma, lej- és ayaki tutnorok (a fhl,: orr és tomk 119033-15044 i,T 1·:Ρ2?Β0024Β I katcinóma, oranjopkaryngtbmák, szájüregi rák {a száj »eraí«£* ás az ajksk; ingták, májáttátek, leukémia, szemhéj dag&tmt, tüdőrák. nyirokcsomó rák;|pö%ki«: / $ös-Htx?gki« ), Hmhlmlk, gyomorrák, rosszindulatá raetenóma, rosszínduJalo neopkkia, gyóSH^felirétidsxér fb&szmduÍató dágtmabá, emlökarejnöim, yégbëlràk* «disliöíjlasiaíömák, trpattörpa, íÍiöáp«Wk%· rnysösás Ibegölägs* oa«Ä tik, srsonnbmä, oetrrebías&btM, psetâk. ycses#dmrelném^ öön-Hodikindipjjim#, oiigodöodPgiÄä, nyelőcső karcinbrna, oszteblMte kareioémák és osztëôplasgdfes karëinémâk, os:zs6ós2ískdmáks peteiësæek-kardndm, hssoyábmngy-karektópm, pífc rák, piaidpoeitőmá, a fej és a nyak pskkeiysejtes karcinőmája (SCCHN), prosztatarák, gatatfäk. rektális katdrtéora, rcbpohlasdóma, hüvelyi rák, paj zstni rigy-kárc iné m a, Schneebergor betegség, oyelftesÍ&ták, spm&liorns, T-sepes iíotföma (mycosis fotgordesj, thymoma, csö-karctnéma. szæm daganatok, hogy cserék, urológiai tumorok, oroiéliáHs ktacmótna.. szetnéremícst rák, szomdíes megjelenés, lágyrész tumorok, MgyszMeb s%arkótn% Plh«4umbg asélmyakmk cs nyelv rák. KiPOnöseo alkalmas példáéi eszírocítómák, giioblasáómák, basnyálmingyrák, tüdőrák, mellrák, vastag- és yéghélrák, petefészek! ak. gyotootrák, glgerii::;, roMkmdelatá tpelanomapa oyeibesöták, méMyákrák, máirak, hólyagrák. és vesesepes rák kezelésére.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12181821.5A EP2703001A1 (en) | 2012-08-26 | 2012-08-26 | Tumor vaccination |
US201261744008P | 2012-09-17 | 2012-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE030407T2 true HUE030407T2 (hu) | 2017-05-29 |
Family
ID=46785268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE13756090A HUE030407T2 (hu) | 2012-08-26 | 2013-08-26 | Tumor vakcinázás |
Country Status (13)
Country | Link |
---|---|
US (1) | US10792483B2 (hu) |
EP (2) | EP2703001A1 (hu) |
JP (1) | JP2015530379A (hu) |
KR (1) | KR101714281B1 (hu) |
CN (1) | CN104640553A (hu) |
AU (1) | AU2013307344B2 (hu) |
CA (1) | CA2879739C (hu) |
ES (1) | ES2586234T3 (hu) |
HU (1) | HUE030407T2 (hu) |
MX (1) | MX357648B (hu) |
RU (1) | RU2015110690A (hu) |
SG (1) | SG11201500396TA (hu) |
WO (1) | WO2014033097A1 (hu) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2703001A1 (en) | 2012-08-26 | 2014-03-05 | XAX Kft. | Tumor vaccination |
US11911629B2 (en) | 2013-03-11 | 2024-02-27 | NeurEM Therapeutics, Inc. | Treatment of primary and metastatic brain cancers by transcranial electromagnetic treatment |
US11759650B2 (en) | 2013-03-11 | 2023-09-19 | NeuroEM Therapeutics, Inc. | Immunoregulation, brain detoxification, and cognitive protection by electromagnetic treatment |
US11752356B2 (en) | 2013-03-11 | 2023-09-12 | NeuroEM Therapeutics, Inc. | Systems for controlling power to differently loaded antenna arrays |
US11813472B2 (en) | 2013-03-11 | 2023-11-14 | NeuroEM Therapeutics, Inc. | Systems for sensing proper emitter array placement |
CN104491464A (zh) * | 2014-11-18 | 2015-04-08 | 四川金堂海纳生物医药技术研究所 | 一种治疗舌体干裂症的内服药物及制备方法 |
EP3515495A4 (en) * | 2016-09-26 | 2020-08-26 | Ensemble Group Holdings | METHOD OF EVALUATION AND TREATMENT OF CANCER IN HUMANS WITH DYSREGULATED LYMPHATIC SYSTEMS |
KR101856904B1 (ko) * | 2017-07-28 | 2018-05-11 | 동아대학교 산학협력단 | Pauf 단백질에 특이적으로 결합하는 항체 및 이의 용도 |
WO2019204507A1 (en) * | 2018-04-18 | 2019-10-24 | Biomadison, Inc. | Methods for determining vaccine potency |
WO2020198145A1 (en) * | 2019-03-22 | 2020-10-01 | The Johns Hopkins University | Gene delivery particles to induce tumor-derived antigen presenting cells |
RU2722268C1 (ru) * | 2019-12-06 | 2020-05-28 | Федеральное государственное автономное образовательное учреждение высшего образования «Дальневосточный федеральный университет» (ДВФУ) | Способ биотерапии лабораторных крыс с перевитой глиобластомой |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57130920A (en) * | 1981-02-09 | 1982-08-13 | Zenyaku Kogyo Kk | Antitumor agent and its preparation |
JPS58157706A (ja) * | 1982-03-12 | 1983-09-19 | Norin Suisansyo Kajiyu Shikenjo | 果樹の摘花剤 |
JPS5936619A (ja) * | 1982-08-23 | 1984-02-28 | Tsumura Juntendo Inc | 制癌補助剤 |
US4712559A (en) * | 1985-06-28 | 1987-12-15 | Bsd Medical Corporation | Local current capacitive field applicator for interstitial array |
US5099756A (en) * | 1989-06-01 | 1992-03-31 | Harry H. Leveen | Radio frequency thermotherapy |
US7429471B2 (en) * | 2000-02-23 | 2008-09-30 | The Trustees Of The University Of Pennsylvania | Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
US6904323B2 (en) | 2003-05-14 | 2005-06-07 | Duke University | Non-invasive apparatus and method for providing RF energy-induced localized hyperthermia |
WO2007077629A1 (ja) * | 2006-01-06 | 2007-07-12 | Cell-Medicine, Inc. | 免疫アジュバント |
US8019414B2 (en) * | 2006-04-05 | 2011-09-13 | Novocure Ltd. | Treating cancer using electromagnetic fields in combination with other treatment regimens |
US20090018613A1 (en) * | 2006-08-02 | 2009-01-15 | Genestim, Llc | Regulation of vascular endothelial growth factor (vegf) gene expression in tissue via the application of electric and/or electromagnetic fields |
DE102006050369A1 (de) * | 2006-10-25 | 2008-04-30 | Oncotherm Kft. | Hyperthermievorrichtung für die selektive Behandlung und die Überwachung von Oberflächengewebe |
WO2009092612A1 (en) | 2008-01-25 | 2009-07-30 | Universitätsklinikum Heidelberg | Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as vehicles for the specific delivery of compounds to the liver |
EP2082777A1 (en) | 2008-01-27 | 2009-07-29 | Oncotherm Kft. | Flexible and porous large-area electrode for heating |
EP2153866A1 (en) * | 2008-08-14 | 2010-02-17 | Oncotherm Kft. | Portable radiofrequency hyperthermia device with flexible treatment electrode for electric field capacitive coupled energy transfer |
EP2174689A1 (en) * | 2008-10-13 | 2010-04-14 | Oncotherm Kft. | Radiofrequency hyperthermia device with target feedback signal modulation |
EP2177336A1 (en) | 2008-10-17 | 2010-04-21 | Grupo Antolin-Ingenieria, S.A. | Method for manufacturing a vehicle trim panel |
GB2476315A (en) | 2009-12-21 | 2011-06-22 | Rec Wafer Norway As | Cleaning a stack of thin wafers |
EP2515995A1 (en) * | 2009-12-23 | 2012-10-31 | Hitops GmbH | New use of pulsed radio frequency |
EP2703001A1 (en) | 2012-08-26 | 2014-03-05 | XAX Kft. | Tumor vaccination |
-
2012
- 2012-08-26 EP EP12181821.5A patent/EP2703001A1/en not_active Withdrawn
-
2013
- 2013-08-26 HU HUE13756090A patent/HUE030407T2/hu unknown
- 2013-08-26 US US14/424,027 patent/US10792483B2/en active Active
- 2013-08-26 ES ES13756090.0T patent/ES2586234T3/es active Active
- 2013-08-26 CA CA2879739A patent/CA2879739C/en active Active
- 2013-08-26 CN CN201380044773.3A patent/CN104640553A/zh active Pending
- 2013-08-26 KR KR1020157005982A patent/KR101714281B1/ko active IP Right Grant
- 2013-08-26 AU AU2013307344A patent/AU2013307344B2/en not_active Ceased
- 2013-08-26 EP EP13756090.0A patent/EP2780024B1/en active Active
- 2013-08-26 JP JP2015528982A patent/JP2015530379A/ja active Pending
- 2013-08-26 WO PCT/EP2013/067653 patent/WO2014033097A1/en active Application Filing
- 2013-08-26 RU RU2015110690A patent/RU2015110690A/ru not_active Application Discontinuation
- 2013-08-26 SG SG11201500396TA patent/SG11201500396TA/en unknown
- 2013-08-26 MX MX2015002578A patent/MX357648B/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR101714281B1 (ko) | 2017-03-09 |
JP2015530379A (ja) | 2015-10-15 |
SG11201500396TA (en) | 2015-02-27 |
CA2879739A1 (en) | 2014-03-06 |
KR20150043375A (ko) | 2015-04-22 |
EP2703001A1 (en) | 2014-03-05 |
MX357648B (es) | 2018-07-18 |
US20150217099A1 (en) | 2015-08-06 |
EP2780024B1 (en) | 2016-05-25 |
US10792483B2 (en) | 2020-10-06 |
MX2015002578A (es) | 2015-06-10 |
CA2879739C (en) | 2017-01-31 |
EP2780024A1 (en) | 2014-09-24 |
RU2015110690A (ru) | 2016-10-20 |
AU2013307344B2 (en) | 2016-08-25 |
AU2013307344A1 (en) | 2015-02-26 |
CN104640553A (zh) | 2015-05-20 |
ES2586234T3 (es) | 2016-10-13 |
WO2014033097A1 (en) | 2014-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2013307344B2 (en) | Tumor vaccination | |
Eranki et al. | High-intensity focused ultrasound (HIFU) triggers immune sensitization of refractory murine neuroblastoma to checkpoint inhibitor therapy | |
Neal et al. | Improved local and systemic anti-tumor efficacy for irreversible electroporation in immunocompetent versus immunodeficient mice | |
Mroz et al. | Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response | |
JP6819012B2 (ja) | 癌と転移を処置するための低密度焦点式超音波 | |
Behm et al. | Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation | |
Camilio et al. | Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model | |
Rao et al. | Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis | |
Kos et al. | Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma | |
Suckow | Cancer vaccines: harnessing the potential of anti-tumor immunity | |
Chi et al. | Putative abscopal effect in three patients treated by combined radiotherapy and modulated electrohyperthermia | |
Koshkina et al. | Autophagy and enhanced chemosensitivity in experimental pancreatic cancers induced by noninvasive radiofrequency field treatment | |
Drilon et al. | Long-term efficacy and safety of larotrectinib in a pooled analysis of patients with tropomyosin receptor kinase (TRK) fusion cancer | |
Yang et al. | Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors | |
Imran et al. | Exploration of novel pathways underlying irreversible electroporation induced anti-tumor immunity in pancreatic cancer | |
Meng et al. | Chemo-immunoablation of solid tumors: A new concept in tumor ablation | |
Ouyang et al. | Thermoseed hyperthermia treatment of mammary orthotopic transplantation tumors in rats and impact on immune function | |
Qu et al. | Precise photodynamic therapy by midkine nanobody-engineered nanoparticles remodels the microenvironment of pancreatic ductal adenocarcinoma and potentiates the immunotherapy | |
Shahbaz et al. | Breast Cancer Vaccination-An Envisioned Future | |
Shabgah et al. | Immunotherapy as an optimal manner in cancer treatment | |
Keisari et al. | In situ ablation of solid tumors by electric forces and its effect on the tumor microenvironment and anti-tumor immunity | |
EP3957318A1 (en) | Pharmaceutical composition | |
Tekewe | VACCINES AND ANTIBODIES FOR CANCER IMMUNOTHERAPY A REVIEW | |
Fu et al. | Remodelling of the tumour-lymph node immune microenvironment promotes T-and NK-cell comobilization for tumour immunotherapy | |
Aremu et al. | Immunotherapy for head and neck cancers |